Evolving strategies in the management of relapsed acute lymphoblastic leukaemia - TMCKidsALLR1 by Prakriti Roy, Jasmeet Sidhu, Rubina Islam, Debparna Saha, Mou Das, Pritha Paul, Shekhar Krishnan, Vaskar Saha

Connect to this object online.

Aberrant TP53 pathways regulate leukaemic cell survival in acute lymphoblastic leukaemia by Pritha Paul, Jizhong Liu, Anthony Moorman, Clare Dempsey, Zhumur Ghosh, Shekhar Krishnan, Cornelia Eckert, Vaskar Saha

Connect to this object online.

Therapeutic drug monitoring informs asparaginase dose scheduling in the InPOG-ALL-15-01-ICiCLe-ALL-14 trial by Jasmeet Sidhu, Debparna Saha, Prakriti Roy, Meghna Banerjee, Pritha Paul, Samik Samaddar, Arindam Basu, Vaskar Saha, Shekhar Krishan

Connect to this object online.

Drug response profiling identifies sensitive synergistic drug combinations for patients with refractory/relapsed acute lymphoblastic leukemia by Jasmeet Sidhu, Shruti Banerjee, Arko Bhowal, Parag Das, Manash Pratim Gogoi, Ritam Siddhanta, Kankana Das, Niharendu Ghara, Pritha Paul, Shekhar Krishnan, Vaskar Saha

Connect to this object online.

Establishment of a biorepository of paediatric cancers: The Tata Medical Center experience by Arindam Basu, Debparna Saha, Rubina Islam, Arunabha Chakrabarti, Anindita Dutta, Meghna Banerjee, Pritha Paul, Sriparna Sadhukhan, Sriparna Giri, Shyamashree Biswas, Mou Das, Prakriti Roy, Sudeshna Dhar, Vaskar Saha, Debdutta Ganguli, Usha Menon, Shekhar Krishnan

Connect to this object online.